Point Prevalence Program
The Point Prevalence Program is a collaborative project between Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group and the Critical Care and Trauma Division of The George Institute. This program aims to streamline future studies in intensive care in Australia and New Zealand and highlight new areas of research.
This program acts as an observational study, without any intervention, and involves collecting data on topics of interest, in patients in multiple intensive care units, on a specific day or days. It provides no information on outcomes, but provides very important information on how common a problem is, and what is currently being done to manage that problem.
This is an ongoing program consisting of multiple research collection days, each performing multiple, independent studies simultaneously, including a number of paediatric studies. For more information please email us.
The George Institute and ANZICS worked collaboratively to:
- Coordinate a systematic program of Point Prevalence studies to facilitate intensive care research in Australia and New Zealand, by providing the infrastructure and mechanisms to perform multiple observational point prevalence studies on a specified day
- Measure compliance with a range of evidence-based processes of care in ICUs in Australia and New Zealand
- Describe how temperature is managed after acute brain injury
The Point Prevalence studies are purely observational, and no intervention is required by the study protocol. The collected data will be entered via a secure password-protected encrypted website (RedCAP).
This project is a bi-national, prospective, observational, multicentre, single-day, point prevalence study of evidence based processes of care using piloted CRF. Research coordinators from each participating institution collect data on all patients who are present in the ICU on the study day. Only fully de-identified data is released to the program’s management centre.
The program has been successful with overwhelming support and participation from Australia and NZ sites. To date we have conducted 7 separate study days, have over 588 records and more than 50 ICUs participating in the most current program. Publications and some presentations have been completed with more in progress. Study investigators plan to continue this program well into the future with Point Prevalence Day 8 set to take place in September 2014.